髂静脉病变支架植入术后支架内再狭窄的研究进展

doi:10.6040/j.issn.1671-7554.0.2024.0685

摘要/Abstract

摘要： 支架植入是髂静脉病变的常用治疗方法。非血栓性髂静脉病变支架术后具有良好的中远期通畅率,但血栓后髂静脉病变支架植入术后则支架内再狭窄发生率较高。目前,有关髂静脉支架后再狭窄的研究报道很少,本文综述了有关髂静脉支架再狭窄的机制及研究进展,以期为该领域的深入研究和防治提供借鉴。

关键词: 髂静脉病变, 血管腔内治疗, 支架, 支架内再狭窄

Abstract: Stent implantation is a common treatment for iliac vein lesions. The stent for non-thrombotic iliac vein lesions has a good long-term patency rate, but the stent for post-thrombotic iliac vein lesions has a high incidence of in-stent restenosis(ISR). However, few studies on ISR after iliac vein stenting have been reported. This article reviewed the research on the mechanism and the current status and progress of prevention and treatment of iliac vein ISR, to provides reference for further research in this field and exploration of prevention and treatment strategies for ISR of iliac venous stent.

Key words: Iliac vein disease, Endovascular treatment, Stenting, In-stent restenosis

中图分类号:

R654.4

尹心怡,李观强,张喜成. 髂静脉病变支架植入术后支架内再狭窄的研究进展[J]. 山东大学学报 (医学版), 2024, 62(11): 8-13.

YIN Xinyi, LI Guanqiang, ZHANG Xicheng. Research advances in mechanism and treatment of in-stent restenosis after iliac vein stenting[J]. Journal of Shandong University (Health Sciences), 2024, 62(11): 8-13.

参考文献

[1] 黄家麒, 刘晓兵, 施慧华, 等. 不同解剖类型非血栓性髂静脉压迫综合征支架植入术后的疗效观察[J]. 中国血管外科杂志(电子版), 2019, 11(3): 195-198. HUANG Jiaqi, LIU Xiaobing, SHI Huihua, et al. The effect of different anatomy types of non-thrombotic iliac vein compression syndrome after stent implantation[J]. Chinese Journal of Vascular Surgery(Electronic Version), 2019, 11(3): 195-198.
[2] Raju S, Owen S Jr, Neglen P. The clinical impact of iliac venous stents in the management of chronic venous insufficiency[J]. J Vasc Surg, 2002, 35(1): 8-15.
[3] Avgerinos ED, Saadeddin Z, Abou Ali AN, et al. Outcomes and predictors of failure of iliac vein stenting after catheter-directed thrombolysis for acute iliofemoral thrombosis[J]. J Vasc Surg Venous Lymphat Disord, 2019, 7(2): 153-161.
[4] Baekgaard N, Broholm R, Just S, et al. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis[J]. Eur J Vasc Endovasc Surg, 2010, 39(1): 112-117.
[5] Haig Y, Enden T, Slagsvold CE, et al. Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis[J]. J Vasc Interv Radiol, 2013, 24(1): 17-24.
[6] Jayaraj A, Fuller R, Raju S, et al. In-stent restenosis and stent compression following stenting for chronic iliofemoral venous obstruction[J]. J Vasc Surg Venous Lymphat Disord, 2022, 10(1): 42-51.
[7] Raju S. Treatment of iliac-caval outflow obstruction[J]. Semin Vasc Surg, 2015, 28(1): 47-53.
[8] Cho H, Kim JW, Hong YS, et al. Stent compression in iliac vein compression syndrome associated with acute ilio-femoral deep vein thrombosis[J]. Korean J Radiol, 2015, 16(4): 723-728.
[9] Hartung O. Results of stenting for postthrombotic venous obstructive lesions[J]. Perspect Vasc Surg Endovasc Ther, 2011, 23(4): 255-260.
[10] Neglén P, Raju S. In-stent recurrent stenosis in stents placed in the lower extremity venous outflow tract[J]. J Vasc Surg, 2004, 39(1): 181-187.
[11] Neglén P, Hollis KC, Olivier J, et al. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result[J]. J Vasc Surg, 2007, 46(5): 979-990.
[12] 邓婵翠. 冠状动脉支架内再狭窄的治疗现状及进展[J]. 心血管病学进展, 2015, 36(6): 747-751. DENG Chancui. Current treatment and prospect of in-stent restenosis[J]. Advances in Cardiovascular Diseases, 2015, 36(6): 747-751.
[13] Williams DM, Nicklas JM, Obi A, et al. Pathologic characteristics of human venous in-stent stenosis and stent occlusion[J]. J Vasc Surg Venous Lymphat Disord, 2023, 11(1): 109-118.
[14] 林跃丽,肖昱东,刘穗玲,等.活检在中心静脉狭窄支架再狭窄治疗的作用[J].实用放射学杂志, 2021, 37(9): 1528-1530. LIN Yueli, XIAO Yudong, LIU Suiling, et al. Effect of biopsy on stent restenosis in central vein stenosis [J]. Journal of Practical Radiology, 2021, 37(9): 1528-1530.
[15] Hoshino Y, Yokoi H. Angioscopic evaluation after venous stents[J]. J Vasc Surg Venous Lymphat Disord, 2023, 11(1): 136-142.
[16] Li GQ, Hu B, Sun Y, et al. Histological features of In-stent restenosis after iliac vein Thrombus removal and stent placement in a goat model[J]. J Vasc Interv Radiol, 2024, 35(4): 611-617.
[17] Raju S, Ward M Jr, Kirk O. A modification of iliac vein stent technique[J]. Ann Vasc Surg, 2014, 28(6): 1485-1492.
[18] Murphy EH, Johns B, Varney E, et al. Deep venous thrombosis associated with caval extension of iliac stents[J]. J Vasc Surg Venous Lymphat Disord, 2017, 5(1): 8-17.
[19] Yang YH, Zhao Y, Chen Z, et al. The effect of stent compression on in-stent restenosis and clinical outcomes in iliac vein compression syndrome[J]. Quant Imaging Med Surg, 2021, 11(6): 2245-2252.
[20] Al-Hakim RA, Kaufman JA, Farsad K. Iliac vein stent placement: acute venographic changes and relevance to venous biomechanics[J]. J Vasc Interv Radiol, 2018, 29(7): 1023-1027.
[21] Funatsu A, Anzai H, Komiyama K, et al. Stent implantation for May-Thurner syndrome with acute deep venous thrombosis: acute and long-term results from the ATOMIC(AcTive stenting for May-Thurner Iliac Compression syndrome)registry[J]. Cardiovasc Interv Ther, 2019, 34(2): 131-138.
[22] Li JY, Wang ZL, Chen CL, et al. Distribution of iliac veins posterior to the common iliac artery bifurcation related to pelvic lymphadenectomy: a digital in vivo anatomical study of 442 Chinese females[J]. Gynecol Oncol, 2016, 141(3): 538-542.
[23] Raju S, Buck WJ, Crim W, et al. Optimal sizing of iliac vein stents[J]. Phlebology, 2018, 33(7): 451-457.
[24] Wentzel JJ, Gijsen FJ, Stergiopulos N, et al. Shear stress, vascular remodeling and neointimal formation[J]. J Biomech, 2003, 36(5): 681-688.
[25] 冯海全, 王淑彪, 王永刚, 等. 不同释放尺度下新型镍钛合金髂静脉支架力学性能和动物实验研究[J]. 生物医学工程学杂志, 2019, 36(6): 1024-1031. FENG Haiquan, WANG Shubiao, WANG Yonggang, et al. Study on mechanical properties of nitinol iliac vein stent and animal test under different release scales[J]. Journal of Biomedical Engineering, 2019, 36(6): 1024-1031.
[26] Hong L, Wang XT, Fang ZD, et al. Editors choice- clinical efficacy of venastent-a novel iliac vein stent for non-thrombotic iliac vein lesions: a multi-centre randomised controlled trial[J]. Eur J Vasc Endovasc Surg, 2022, 63(6): 883-889.
[27] Stuck AK, Kunz S, Baumgartner I, et al. Patency and clinical outcomes of a dedicated, self-expanding, hybrid oblique stent used in the treatment of common iliac vein compression[J]. J Endovasc Ther, 2017, 24(1): 159-166.
[28] De Maeseneer MG, Kakkos SK, Aherne T, et al. Editors choice-European society for vascular surgery(ESVS)2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs[J]. Eur J Vasc Endovasc Surg, 2022, 63(2): 184-267.
[29] Williams ZF, Dillavou ED. A systematic review of venous stents for iliac and venacaval occlusive disease[J]. J Vasc Surg Venous Lymphat Disord, 2020, 8(1): 145-153.
[30] Raju S, Kirk O, Davis M, et al. Hemodynamics of “critical” venous stenosis and stent treatment[J]. J Vasc Surg Venous Lymphat Disord, 2014, 2(1): 52-59.
[31] Raju S, Johns B, Alias M, et al. Hyperdilatation for iliac vein stent compression and In-stent restenosis[J]. J Vasc Surg Venous Lymphatic Disord, 2016, 4(1): 138.
[32] 吕家颉,王旭辉,王鹏辉,等. 髂静脉支架植入术后支架再狭窄危险因素的研究进展[J]. 中国血管外科杂志(电子版), 2023, 15(4): 370-373.
[33] Robertson B, Shapiro J, Muck A, et al. Venous stent patency is independent of total stented length in nonthrombotic iliac vein and post-thrombotic venous stenoses[J]. J Vasc Surg Venous Lymphat Disord, 2023, 11(2): 339-345.
[34] van Vuuren T, Wittens C, de Graaf R. Stent extension below the common femoral vein in extensive chronic iliofemoral venous obstructions[J]. J Vasc Interv Radiol, 2018, 29(8): 1142-1147.
[35] Ardita V, Galati N, Miglioranza E, et al. Endovascular treatment of chronic ilio-femoral vein obstruction with extension below the inguinal ligament in patients with post-thrombotic syndrome[J]. J Vasc Surg Venous Lymphat Disord, 2024, 12(3): 101816.
[36] Kölbel T, Lindh M, Holst J, et al. Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement[J]. J Vasc Interv Radiol, 2007, 18(2): 243-250.
[37] Oguzkurt L, Tercan F, Ozkan U, et al. Iliac vein compression syndrome: outcome of endovascular treatment with long-term follow-up[J]. Eur J Radiol, 2008, 68(3): 487-492.
[38] Blix K, Jensvoll H, Brækkan SK, et al. White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism: the Tromsø study[J]. PLoS One, 2013, 8(9): e73447. doi:10.1371/journal.pone.0073447.
[39] Pabinger I, Posch F. Flamethrowers: blood cells and cancer thrombosis risk[J]. Hematology Am Soc Hematol Educ Program, 2014, 2014(1): 410-417.
[40] Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: a bench to bedside review[J]. Thromb Res, 2020, 192: 40-51. doi:10.1016/j.thromres.2020.05.008.
[41] Cosman F, Baz-Hecht M, Cushman M, et al. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature[J]. Thromb Res, 2005, 116(1): 1-13.
[42] Grimnes G, Horvei LD, Tichelaar V, et al. Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study[J]. Haematologica, 2016, 101(10): e401-e404. doi:10.3324/haematol.2016.145151.
[43] Harrison RL, McKee PA. Estrogen stimulates von Willebrand factor production by cultured endothelial cells[J]. Blood, 1984, 63(3): 657-664.
[44] Milinis K, Thapar A, Shalhoub J, et al. Antithrombotic therapy following venous stenting: international Delphi consensus[J]. Eur J Vasc Endovasc Surg, 2018, 55(4): 537-544.
[45] Hald EM, Brækkan SK, Mathiesen EB, et al. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromsø study[J]. Haematologica, 2011, 96(8): 1189-1194.
[46] Guo BL, Chen C, Li YL, et al. Principles of Optimal Antithrombotic Therapy for Iliac VEnous Stenting(POATIVES): a national expert-based Delphi consensus study[J]. J Vasc Surg Venous Lymphat Disord, 2024, 12(2): 101739.
[47] Yuan LX, Lu Y, Zhu GL, et al. Endovascular treatment for iliofemoral vein thrombosis with composite stents[J]. Ann Vasc Surg, 2018, 51: 262-268.
[48] Lookstein RA, Haruguchi H, Ouriel K, et al. Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas[J]. N Engl J Med, 2020, 383(8): 733-742.
[49] Lei JH, Pu HJ, Zhang LJ, et al. Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: a single-arm observational study[J]. Catheter Cardiovasc Interv, 2024, 103(5): 752-757.
[50] 李楠, 曾妮, 陈斌, 等. 裸支架与覆膜支架植入治疗血液透析患者中心静脉完全闭塞的临床疗效比较[J]. 中华肾脏病杂志, 2019, 35(3): 198-203. LI Nan, ZENG Ni, CHEN Bin, et al. Comparison of clinical effects of bare stent and covered metal stent graft in the treatment of complete occlusion of central venography in hemodialysis patients[J]. Chinese Journal of Nephrology, 2019, 35(3): 198-203.
[51] Dolmatch B, Cabrera T, Pergola P, et al. Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis[J]. Kidney Int, 2023, 104(1): 189-200.
[52] Masrani A, Soni J, Turba U, et al. Comparing secondary patency of covered and bare stents in hemodialysis patients: a 2-year study[J]. CardioVasc Inter Rad, 2016, 39(suppl 3): S162.
[53] Topaz O, Minisi AJ, Bernardo N, et al. Comparison of effectiveness of excimer laser angioplasty in patients with acute coronary syndromes in those with versus those without normal left ventricular function[J]. Am J Cardiol, 2003, 91(7): 797-802.
[54] Jayaraj A, Fuller R, Raju S. Role of laser ablation in recalcitrant instent restenosis post iliofemoral venous stenting[J]. J Vasc Surg Cases Innov Tech, 2021, 7(2): 298-301.
[55] Cho S, Han A, Ahn S, et al. Directional atherectomy for treating in-stent restenosis of the superficial femoral artery[J]. Vasc Specialist Int, 2020, 36(3): 136-143.
[56] Robertson C, Varcoe RL, Black S, et al. Histopathology of iliocaval venous in-stent restenosis treated with directional atherectomy[J]. J Endovasc Ther, 2019, 26(5): 742-746.
[57] Schmidt JO, Christensen JK, Houlind KC. Calcified in-stent restenosis in a venous stent[J]. J Vasc Surg Cases, 2015, 1(4): 261-263.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed